Asthma. After reviewing the websites Healthy People 2030 and Morbidity Frequency Measures (located within the module Reading and Resources area), write a journal relating the HP2030 goals to the disease you chose for your final project.

Be sure to address the following:

Identify any goals specific to the disease you selected.
Are the goals specific to your disease adequate? Why or why not?
How prevalent is your particular disease in the United States? How prevalent is it worldwide?
Be sure to support your response with relevant resources, which should be cited according to APA Paper Writing Service by Expert Writers Pro Paper Help: Essay Writing Service Paper Writing Service by Essay Pro Paper Help: Essay Writing Service style.

Submit your assignment here. Make sure you’ve included all the required elements by reviewing the guidelines and rubric.

Asthma Goals and Prevalence: An Analysis of Healthy People 2030 Objectives

Asthma is a chronic inflammatory lung disease characterized by airway hyperresponsiveness and obstruction (Centers for Disease Control and Prevention, 2020). It affects over 25 million Americans and is one of the most common chronic diseases among children (CDC, 2020). Globally, asthma affects an estimated 339 million people and causes over 400,000 deaths per year (World Health Organization, 2022). Given the widespread impact of this condition, the goals and targets outlined in Healthy People 2030 aim to reduce asthma prevalence and morbidity in the United States.
Healthy People Goals for Asthma
Research Paper Writing Service: Professional Help in Research Projects for Students – One of the overarching goals of Healthy People 2030 is to achieve health equity, eliminate disparities, and improve the health of all groups (Office of Disease Prevention and Health Promotion, n.d.). This goal directly relates to asthma, as the burden of this disease disproportionately impacts some populations. Specifically, Healthy People 2030 sets an objective (RES-11) to reduce asthma episodes among children and adults, with targets to decrease the number of hospital discharges and emergency department visits due to asthma exacerbations (ODPHP, n.d.). Additionally, objective RES-12 aims to increase the proportion of persons with current asthma who receive formal patient education (ODPHP, n.d.).
Asthma Prevalence in the U.S. and Globally
According to the CDC (2020), over 25 million Americans currently have asthma, including over 6 million children. Rates vary by state but nationwide, asthma affects 1 in 13 people (CDC, 2020). Morbidity rates also differ among demographic groups, with higher prevalence among Puerto Rican, American Indian/Alaska Native, and non-Hispanic black populations (CDC, 2020). Globally, the WHO (2022) estimates 339 million people have asthma, with the highest rates in countries like Australia, the United Kingdom, and the United States. Asthma causes over 400,000 deaths per year worldwide, with the majority of fatalities occurring in low- and lower-middle income countries (WHO, 2022).
The goals outlined in Healthy People 2030 aim to reduce asthma morbidity through decreasing exacerbations requiring medical care and increasing patient education. However, given the widespread impact and health inequities associated with asthma, bolder national targets are needed to achieve significant reductions in prevalence and disparities. Community-based interventions, culturally-competent care models, and addressing social determinants of health could help lower rates, especially among disproportionately burdened populations. Overall, while Healthy People 2030 objectives represent progress, more aggressive asthma goals are required to curb this chronic disease’s enormous global burden.
Centers for Disease Control and Prevention. (2020, August 17). Most recent national asthma data.
Office of Disease Prevention and Health Promotion. (n.d.). Respiratory diseases. Healthy People 2030. U.S. Department of Health and Human Services. research essay writing help.
World Health Organization. (2022, February 23). Asthma.

Published by
View all posts